30 results
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
the benefit of those transactions if Kineta is unable to successfully integrate them with Kineta’s existing operations and company culture, which could
424B3
KA
Kineta Inc
10 Nov 22
Prospectus supplement
4:21pm
operations and company culture. In addition, if Yumanity’s agreement with any of its collaborators terminates, Yumanity’s access to technology … to successfully integrate them with its existing operations and company culture. Yumanity may encounter numerous difficulties in developing, manufacturing
8-K
EX-10.1
7j2hmcg36qbv1w7
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
kwpbe1iq
17 May 21
Regulation FD Disclosure
5:03pm
8-K/A
EX-99.1
ilh4ba5pg z83r6h
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.3
x33pag6apeodcson74bg
3 Feb 21
Other Events
4:59pm